IN2013MU03855A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03855A
IN2013MU03855A IN3855MU2013A IN2013MU03855A IN 2013MU03855 A IN2013MU03855 A IN 2013MU03855A IN 3855MU2013 A IN3855MU2013 A IN 3855MU2013A IN 2013MU03855 A IN2013MU03855 A IN 2013MU03855A
Authority
IN
India
Prior art keywords
relates
bendamustine
salt
pharmaceutical compositions
compositions
Prior art date
Application number
Other languages
English (en)
Inventor
Brij Khera
Sushrut Krishnaji Kulkarni
Debjani Manoj Singh
Tushar Surajmal Nahata
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN3855MU2013 priority Critical patent/IN2013MU03855A/en
Publication of IN2013MU03855A publication Critical patent/IN2013MU03855A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3855MU2013 2013-12-10 2013-12-10 IN2013MU03855A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3855MU2013 IN2013MU03855A (de) 2013-12-10 2013-12-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3855MU2013 IN2013MU03855A (de) 2013-12-10 2013-12-10

Publications (1)

Publication Number Publication Date
IN2013MU03855A true IN2013MU03855A (de) 2015-08-07

Family

ID=54398090

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3855MU2013 IN2013MU03855A (de) 2013-12-10 2013-12-10

Country Status (1)

Country Link
IN (1) IN2013MU03855A (de)

Similar Documents

Publication Publication Date Title
JOP20200192A1 (ar) أجسام مضادة لـ tigit
MX2015009105A (es) Composiciones en solucion solida y su uso en inflamacion cronica.
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
MX2015009058A (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
MX2022007522A (es) Anticuerpos anti-cd27.
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
MA39710A (fr) Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
MX2015009045A (es) Composiciones y metodos para tratar el dolor severo.
BR112018003526A2 (pt) métodos de tratamento de doenças inflamatórias
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
NZ730092A (en) Use of cysteamine in treating infections caused by yeasts/moulds
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
MX2019000677A (es) Células miméticas de células b.
PH12017500923A1 (en) New dosage and use of a a2a antagonist
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
PH12017501979A1 (en) Pharmaceutical compound
IN2013MU03855A (de)
CY1117740T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
DOP2015000290A (es) Benzoxazoles sustituidos
PH12020500472A1 (en) Autotaxin inhibitor compounds
PH12017501982A1 (en) Pharmaceutical compound